CINDA INTL HLDG(00111): Extend the public listing for the sale of two subsidiary companies.
Sinopharm International Holdings (00111) announced that it will publicly list Sinopharm International Shanghai and Sinopharm Leading for sale.
CINDA INTL HLDG (00111) announced the public listing for the sale of 100% equity of Cinda International Shanghai and Cinda Leading, as disclosed in a previous announcement. The listing for sale will be open for 20 business days starting from August 22, 2024 (excluding Chinese public holidays). The tender period will end on September 19, 2024, and the company did not receive any bids from public listing bidders. Therefore, the Board of Directors has decided to extend the public listing under the same conditions until a successful bidder is found, but the extension will not exceed 1 year from the date of the public listing announcement.
Related Articles

NVIDIA Corporation (NVDA.US) is reported to be "internalizing" DGX Cloud, no longer focusing on external sales.

Tesla, Inc. (TSLA.US) stock price rises to an 8-month high, the board supports Musk

HK Bull/Bear Outstanding Qty Ratio(66:34) | September 13th
NVIDIA Corporation (NVDA.US) is reported to be "internalizing" DGX Cloud, no longer focusing on external sales.

Tesla, Inc. (TSLA.US) stock price rises to an 8-month high, the board supports Musk

HK Bull/Bear Outstanding Qty Ratio(66:34) | September 13th

RECOMMEND

Hong Kong Stock Concept Tracker|Oracle (ORCL.US) RPO Surge Ignites AI Computing Power Chain—Domestic Opportunities in Focus
11/09/2025

Southbound Capital Flows Shift: Profit-Taking on High-Flying Stocks and Accumulating Alibaba and Tence
11/09/2025

Anti-Involution Policies Deliver Results as August Price Indicators Improve
11/09/2025